Matthias Bräutigam - Concepedia

Author

Matthias Bräutigam

Also Known As

M Brautigam, M Bräutigam, M. BRAUTIGAM, M. BRÁUTIGAM, M. BRÄUTIGAM, M. Brautigam, M. BrÃ¤utigam, M. Bräutigam, M.R.H. Brautigam, MATTHIAS BRAUTIGAM

132

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Novartis (Germany)Novartis (Switzerland)Charité - Universitätsmedizin Berlin University of Münster Christian-Albrechts-Universität zu Kiel

About

Matthias Bräutigam is an author at Novartis (Germany) specializing in medicine, dermatology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.5K
2	Allergy	8	8	907
3	Engineering	2	2	49
4	Natural Sciences	1	1	20
5	Social Sciences	1	1	39

Matthias Bräutigam

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase Marcus Maurer, Sabine Altrichter, Thomas Bieber, Journal of Allergy and Clinical Immunology AllergyAutoimmune DiseaseAllergy MedicineImmunologyAllergen	2011	354
Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study Michael J. Meurer, Regina Fölster‐Holst, Gottfried Wozel, Dermatology	2002	220
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis Jens‐Michael Jensen, Stephan Pfeiffer, Magdalena Witt, Journal of Allergy and Clinical Immunology Skin BarrierAllergyAtopic DermatitisAllergy MedicineDifferent Effects	2009	165
Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection Matthias Bräutigam, Siegfried Nolting, R.E. Schopf, BMJ	1995	144
Effect of omalizumab on angioedema in H <sub>1</sub> ‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ <scp>ACT</scp> , a randomized controlled trial Petra Staubach, Martin Metz, Nadine Chapman‐Rothe, Allergy	2016	128
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis Jens‐Michael Jensen, Stephan Pfeiffer, Magdalena Witt, Journal of Allergy and Clinical Immunology Skin BarrierAllergyAtopic DermatitisAllergy MedicineDifferent Effects	2009	107
Nail incorporation kinetics of terbinafine in onychomycosis patients Friedrich Schatz, Matthias Bräutigam, E. DOBROWOLSKI, Clinical and Experimental Dermatology	1995	99
Terbinafine in onychomycosis with involvement by non-dermatophytic fungi Siegfried Nolting, Matthias Bräutigam, Gottfried Weidinger British Journal of Dermatology	1994	95
A body-weight–independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life Wolfgang Czech, Matthias Bräutigam, Gottfried Weidinger, Journal of the American Academy of Dermatology Cyclosporine MicroemulsionAllergyAtopic DermatitisAllergy MedicineMedicine	2000	88
Pimecrolimus cream 1% in erosive oral lichen planus- a prospective randomized double-blind vehicle-controlled study Thomas Volz, Ulrich M. Caroli, Holger Lüdtke, British Journal of Dermatology	2008	82

Page 1